Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2008, Article ID 219241, 9 pages
http://dx.doi.org/10.1155/2008/219241
Research Article

Stat3 Expression and Its Correlation with Proliferation and Apoptosis/Autophagy in Gliomas

1Neuro-bio-oncology Center, Policlinico di Monza Foundation, University of Turin, Via Pietro Micca, 29, 13100 Vercelli, Italy
2Clinical and Experimental Medical Department, University of East Piedmont, 28100 Novara, Italy
3Department of Chemical, Food, Pharmaceutical and Pharmacological Sciences (DISCAFF), University of East Piedmont, 28100 Novara, Italy

Received 2 July 2008; Accepted 24 November 2008

Academic Editor: Massimo Aglietta

Copyright © 2008 Valentina Caldera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. E. Levy and J. E. Darnell Jr., “STATs: transcriptional control and biological impact,” Nature Reviews Molecular Cell Biology, vol. 3, no. 9, pp. 651–662, 2002. View at Publisher · View at Google Scholar
  2. T. Bowman, R. Garcia, J. Turkson, and R. Jove, “STATs in oncogenesis,” Oncogene, vol. 19, no. 21, pp. 2474–2488, 2000. View at Publisher · View at Google Scholar
  3. P. K. Epling-Burnette, J. H. Liu, R. Catlett-Falcone et al., “Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression,” The Journal of Clinical Investigation, vol. 107, no. 3, pp. 351–361, 2001. View at Publisher · View at Google Scholar
  4. S. O. Rahaman, P. C. Harbor, O. Chernova, G. H. Barnett, M. A. Vogelbaum, and S. J. Haque, “Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells,” Oncogene, vol. 21, no. 55, pp. 8404–8413, 2002. View at Publisher · View at Google Scholar
  5. J. F. Bromberg, M. H. Wrzeszczynska, G. Devgan et al., “Stat3 as an oncogene,” Cell, vol. 98, no. 3, pp. 295–303, 1999. View at Publisher · View at Google Scholar
  6. N. Kiuchi, K. Nakajima, M. Ichiba et al., “STAT3 is required for the gp130-mediated full activation of the c-myc gene,” The Journal of Experimental Medicine, vol. 189, no. 1, pp. 63–73, 1999. View at Publisher · View at Google Scholar
  7. J. Weissenberger, S. Loeffler, A. Kappeler et al., “IL-6 is required for glioma development in a mouse model,” Oncogene, vol. 23, no. 19, pp. 3308–3316, 2004. View at Publisher · View at Google Scholar
  8. A. Iwamaru, S. Szymanski, E. Iwado et al., “A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo,” Oncogene, vol. 26, no. 17, pp. 2435–2444, 2007. View at Publisher · View at Google Scholar
  9. O. Fujita, M. Asanuma, T. Yokoyama, I. Miyazaki, N. Ogawa, and H. Kumon, “Involvement of STAT3 in bladder smooth muscle hypertrophy following bladder outlet obstruction,” Acta Medica Okayama, vol. 60, no. 6, pp. 299–309, 2006. View at Google Scholar
  10. H. Wang, H. Wang, W. Zhang, H. J. Huang, W. S. L. Liao, and G. N. Fuller, “Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas,” Laboratory Investigation, vol. 84, no. 8, pp. 941–951, 2004. View at Publisher · View at Google Scholar
  11. M. Mizoguchi, R. A. Betensky, T. T. Batchelor, D. C. Bernay, D. N. Louis, and C. L. Nutt, “Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival,” Journal of Neuropathology and Experimental Neurology, vol. 65, no. 12, pp. 1181–1188, 2006. View at Publisher · View at Google Scholar
  12. H.-W. Lo, S.-C. Hsu, W. Xia et al., “Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression,” Cancer Research, vol. 67, no. 19, pp. 9066–9076, 2007. View at Publisher · View at Google Scholar
  13. F. Lefranc and R. Kiss, “Autophagy, the Trojan horse to combat glioblastomas,” Neurosurgical Focus, vol. 20, no. 4, p. E7, 2006. View at Publisher · View at Google Scholar
  14. T. Yokoyama, Y. Kondo, and S. Kondo, “Roles of mTOR and STAT3 in autophagy induced by telomere 3 overhang-specific DNA oligonucleotides,” Autophagy, vol. 3, no. 5, pp. 496–498, 2007. View at Google Scholar
  15. Y. Kondo, T. Kanzawa, R. Sawaya, and S. Kondo, “The role of autophagy in cancer development and response to therapy,” Nature Reviews Cancer, vol. 5, no. 9, pp. 726–734, 2005. View at Publisher · View at Google Scholar
  16. D. C. Rubinsztein, J. E. Gestwicki, L. O. Murphy, and D. J. Klionsky, “Potential therapeutic applications of autophagy,” Nature Reviews Drug Discovery, vol. 6, no. 4, pp. 304–312, 2007. View at Publisher · View at Google Scholar
  17. I. Tanida, T. Ueno, and E. Kominami, “LC3 conjugation system in mammalian autophagy,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 12, pp. 2503–2518, 2004. View at Publisher · View at Google Scholar
  18. A. Waha, B. Rollbrocker, O. D. Wiestler, and A. von Deimling, “A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors,” Diagnostic Molecular Pathology, vol. 5, no. 2, pp. 147–150, 1996. View at Publisher · View at Google Scholar
  19. B. K. A. Rasheed, T. T. Stenzel, R. E. McLendon et al., “PTEN gene mutations are seen in high-grade but not in low-grade gliomas,” Cancer Research, vol. 57, no. 19, pp. 4187–4190, 1997. View at Google Scholar
  20. B. Actor, J. M. J. Ludwig Cobbers, R. Büschges et al., “Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components,” Genes Chromosomes and Cancer, vol. 34, no. 4, pp. 416–427, 2002. View at Publisher · View at Google Scholar
  21. M. Dolled-Filhart, R. L. Camp, D. P. Kowalski, B. L. Smith, and D. L. Rimm, “Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis,” Clinical Cancer Research, vol. 9, no. 2, pp. 594–600, 2003. View at Google Scholar
  22. D. Schiffer, Brain Tumor Pathology: Current Diagnostic Hotspots and Pitfalls, Springer, Dordrecht, The Netherlands, 2006.
  23. S. Bhattacharya, R. M. Ray, and L. R. Johnson, “STAT3-mediated transcription of Bcl-2, Mcl-1 and C-IAP2 prevents apoptosis in polyamine-depleted cells,” Biochemical Journal, vol. 392, no. 2, pp. 335–344, 2005. View at Publisher · View at Google Scholar
  24. G. Niu, T. Bowman, M. Huang et al., “Roles of activated Src and Stat3 signaling in melanoma tumor cell growth,” Oncogene, vol. 21, no. 46, pp. 7001–7010, 2002. View at Publisher · View at Google Scholar
  25. L. Konnikova, M. C. Simeone, M. M. Kruger, M. Kotecki, and B. H. Cochran, “Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells,” Cancer Research, vol. 65, no. 15, pp. 6516–6520, 2005. View at Publisher · View at Google Scholar
  26. N. Meydan, T. Grunberger, H. Dadi et al., “Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor,” Nature, vol. 379, no. 6566, pp. 645–648, 1996. View at Publisher · View at Google Scholar
  27. M. Mellai and D. Schiffer, “Apoptosis in brain tumors: prognostic and therapeutic considerations,” Anticancer Research, vol. 27, no. 1A, pp. 437–448, 2007. View at Google Scholar
  28. A. Gross, X.-M. Yin, K. Wang et al., “Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death,” The Journal of Biological Chemistry, vol. 274, no. 2, pp. 1156–1163, 1999. View at Publisher · View at Google Scholar
  29. D. M. Ashley, C. D. Riffkin, A. M. Muscat et al., “Caspase 8 is absent or low in many ex vivo gliomas,” Cancer, vol. 104, no. 7, pp. 1487–1496, 2005. View at Publisher · View at Google Scholar
  30. A. Chakravarti, G. Zhai, Y. Suzuki et al., “The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas,” Journal of Clinical Oncology, vol. 22, no. 10, pp. 1926–1933, 2004. View at Publisher · View at Google Scholar
  31. L. K. Schaefer, Z. Ren, G. N. Fuller, and T. S. Schaefer, “Constitutive of Stat3α in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2),” Oncogene, vol. 21, no. 13, pp. 2058–2065, 2002. View at Publisher · View at Google Scholar
  32. M.-A. Bjornsti and P. J. Houghton, “The TOR pathway: a target for cancer therapy,” Nature Reviews Cancer, vol. 4, no. 5, pp. 335–348, 2004. View at Publisher · View at Google Scholar
  33. C. Vande Velde, J. Cizeau, D. Dubik et al., “BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore,” Molecular and Cellular Biology, vol. 20, no. 15, pp. 5454–5468, 2000. View at Publisher · View at Google Scholar
  34. C. Miracco, E. Cosci, G. Oliveri et al., “Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours,” International Journal of Oncology, vol. 30, no. 2, pp. 429–436, 2007. View at Google Scholar
  35. H. Takeuchi, Y. Kondo, K. Fujiwara et al., “Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors,” Cancer Research, vol. 65, no. 8, pp. 3336–3346, 2005. View at Google Scholar
  36. K. C. Yao, T. Komata, Y. Kondo, T. Kanzawa, S. Kondo, and I. M. Germano, “Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy,” Journal of Neurosurgery, vol. 98, no. 2, pp. 378–384, 2003. View at Google Scholar
  37. S. Daido, A. Yamamoto, K. Fujiwara, R. Sawaya, S. Kondo, and Y. Kondo, “Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy,” Cancer Research, vol. 65, no. 10, pp. 4368–4375, 2005. View at Publisher · View at Google Scholar
  38. H. Ito, S. Daido, T. Kanzawa, S. Kondo, and Y. Kondo, “Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells,” International Journal of Oncology, vol. 26, no. 5, pp. 1401–1410, 2005. View at Google Scholar